Company Registration No. 05919851 (England and Wales)
LONDON WOMEN'S CLINIC
(DARLINGTON) LIMITED
ANNUAL REPORT AND
FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 OCTOBER 2023
PAGES FOR FILING WITH REGISTRAR
LONDON WOMEN'S CLINIC (DARLINGTON) LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 9
LONDON WOMEN'S CLINIC (DARLINGTON) LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2023
31 October 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
6
236,699
86,097
Current assets
Stocks
57,498
31,416
Debtors
7
1,279,983
985,642
Cash at bank and in hand
126,049
137,503
1,463,530
1,154,561
Creditors: amounts falling due within one year
8
(729,044)
(553,565)
Net current assets
734,486
600,996
Total assets less current liabilities
971,185
687,093
Provisions for liabilities
(42,090)
-
0
Net assets
929,095
687,093
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
928,995
686,993
Total equity
929,095
687,093

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 1 March 2024 and are signed on its behalf by:
D Williams
Director
Company Registration No. 05919851
LONDON WOMEN'S CLINIC (DARLINGTON) LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 OCTOBER 2023
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 November 2021
100
562,339
562,439
Year ended 31 October 2022:
Profit and total comprehensive income for the year
-
486,993
486,993
Dividends
-
(362,339)
(362,339)
Balance at 31 October 2022
100
686,993
687,093
Year ended 31 October 2023:
Profit and total comprehensive income for the year
-
728,995
728,995
Dividends
-
(486,993)
(486,993)
Balance at 31 October 2023
100
928,995
929,095
LONDON WOMEN'S CLINIC (DARLINGTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
- 3 -
1
Accounting policies
Company information

London Women's Clinic (Darlington) Limited is a private company limited by shares incorporated in England and Wales. The registered office is 113-115 Harley Street, London, W1G 6AP.

 

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future, however, the lease regarding space at Woodlands Hospital has not yet been formally renewed thereby creating an uncertainty. The directors however believe this is merely a timing issue and formality and thus continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover
Turnover represents amounts receivable for goods and services rendered in the year.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.4
Intangible fixed assets - goodwill

Acquired goodwill is written off in equal annual instalments over its estimated useful economic life, which is now fully amortised.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

LONDON WOMEN'S CLINIC (DARLINGTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
1
Accounting policies
(Continued)
- 4 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold building improvements
Over the remaining life of the lease
Plant and machinery
10 years straight line
Fixtures, fittings and equipment
10 years straight line
Computer equipment
3 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts.

LONDON WOMEN'S CLINIC (DARLINGTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
1
Accounting policies
(Continued)
- 5 -
1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

LONDON WOMEN'S CLINIC (DARLINGTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
1
Accounting policies
(Continued)
- 6 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.12
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Deferred income

Where an invoice has been raised but the service has yet to be provided, the directors defer an estimated amount of the income to represent the period in which the services will be provided.

With regard to storage fees provided by the Company, income is fully recognised in the year of invoicing.

Useful lives of assets

The directors have considered the useful economic life of the fixed assets and on that basis have estimated the depreciation rate that should be used by the Company. Where new information becomes available in this regard the Directors consider the materiality of any potential adjustments and where necessary revise their useful economic life assessment.

Debtor recoverability

At the balance sheet date, the directors consider the recoverability of the amounts owed to the company utilising post balance sheet information where available. Where balances are not considered recoverable appropriate provisions are made.

With regard to trade debtors, determining the recoverability of debtors requires an estimation of the average time period that self-funded debtors will pay. The directors consider 180 days to be a reasonable estimate.

LONDON WOMEN'S CLINIC (DARLINGTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
- 7 -
3
Auditor's remuneration

The company uses common facilities with other group undertakings for which management charges are rendered by the ultimate parent undertaking. Included within those charges are amounts for staff and administrative costs together with audit fees of £8,000 (2022 : £9,000) and fees of £1,420 (2022 : £1,420) for taxation services.

 

Neither of the directors received any remuneration for their services direct from the company.

4
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
-
0
-
0
5
Intangible fixed assets
Goodwill
£
Cost
At 1 November 2022 and 31 October 2023
(348,939)
Amortisation and impairment
At 1 November 2022 and 31 October 2023
(348,939)
Carrying amount
At 31 October 2023
-
0
At 31 October 2022
-
0
LONDON WOMEN'S CLINIC (DARLINGTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
- 8 -
6
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 November 2022
273,782
547,052
820,834
Additions
10,616
184,778
195,394
Disposals
-
0
(67,165)
(67,165)
Transfers
-
0
6,768
6,768
At 31 October 2023
284,398
671,433
955,831
Depreciation and impairment
At 1 November 2022
273,782
460,955
734,737
Depreciation charged in the year
708
27,093
27,801
Eliminated in respect of disposals
-
0
(48,302)
(48,302)
Transfers
-
0
4,896
4,896
At 31 October 2023
274,490
444,642
719,132
Carrying amount
At 31 October 2023
9,908
226,791
236,699
At 31 October 2022
-
0
86,097
86,097
7
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
268,133
245,362
Amounts owed by group undertakings
969,216
696,049
Other debtors
42,634
44,231
1,279,983
985,642
8
Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
283,505
179,912
Other creditors
445,539
373,653
729,044
553,565
LONDON WOMEN'S CLINIC (DARLINGTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
- 9 -
9
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

Senior Statutory Auditor:
Carol Cheesman
Statutory Auditor:
Cheesmans
10
Financial commitments, guarantees and contingent liabilities

There is a fixed and floating charge between the companies of the J D Healthcare Group under the terms of which amounts due to HSBC Bank Plc are secured on the assets of all group companies. There have been no instances in the year or to date whereby the obligations under this debenture have been breached and therefore this debenture is not currently enforceable.

 

The company participates in a cross guarantee with other companies in the group and associated companies. There is a composite company unlimited multilateral guarantee between J D Healthcare Limited, The Bridge Centre Limited and HSBC Bank Plc, whereby amounts due to and from HSBC Bank Plc can be offset.

 

11
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2023
2022
£
£
-
0
39,129
12
Related party transactions

Transactions with related parties

The company has taken advantage of the exemptions available whereby it has not disclosed transactions with the parent company, the ultimate parent company, or any wholly owned subsidiary undertakings of the group.

13
Ultimate parent company

The parent company of London Women's Clinic (Darlington) Limited is Harley Street Women's Clinic Limited. The registered office of Harley Street Women's Clinic Limited is 113-115 Harley Street, London, W1G 6AP.

 

The ultimate parent company of London Women’s Clinic (Darlington) Limited is J D Healthcare Limited. The registered office of J D Healthcare Limited is 113-115 Harley Street, London, W1G 6AP.

2023-10-312022-11-01false01 March 2024CCH SoftwareCCH Accounts Production 2023.100No description of principal activityThis audit opinion is unqualifiedK AhujaD Williams059198512022-11-012023-10-31059198512023-10-31059198512022-10-3105919851core:LandBuildings2023-10-3105919851core:OtherPropertyPlantEquipment2023-10-3105919851core:LandBuildings2022-10-3105919851core:OtherPropertyPlantEquipment2022-10-3105919851core:CurrentFinancialInstrumentscore:WithinOneYear2023-10-3105919851core:CurrentFinancialInstrumentscore:WithinOneYear2022-10-3105919851core:CurrentFinancialInstruments2023-10-3105919851core:CurrentFinancialInstruments2022-10-3105919851core:ShareCapital2023-10-3105919851core:ShareCapital2022-10-3105919851core:RetainedEarningsAccumulatedLosses2023-10-3105919851core:RetainedEarningsAccumulatedLosses2022-10-3105919851core:ShareCapital2021-10-3105919851core:RetainedEarningsAccumulatedLosses2021-10-31059198512021-10-3105919851bus:Director22022-11-012023-10-3105919851core:RetainedEarningsAccumulatedLosses2021-11-012022-10-31059198512021-11-012022-10-3105919851core:RetainedEarningsAccumulatedLosses2022-11-012023-10-3105919851core:Goodwill2022-11-012023-10-3105919851core:LandBuildingscore:LongLeaseholdAssets2022-11-012023-10-3105919851core:LeaseholdImprovements2022-11-012023-10-3105919851core:PlantMachinery2022-11-012023-10-3105919851core:FurnitureFittings2022-11-012023-10-3105919851core:NetGoodwill2022-10-3105919851core:NetGoodwill2023-10-3105919851core:NetGoodwill2022-10-3105919851core:LandBuildings2022-10-3105919851core:OtherPropertyPlantEquipment2022-10-31059198512022-10-3105919851core:LandBuildings2022-11-012023-10-3105919851core:OtherPropertyPlantEquipment2022-11-012023-10-3105919851core:WithinOneYear2023-10-3105919851core:WithinOneYear2022-10-3105919851bus:PrivateLimitedCompanyLtd2022-11-012023-10-3105919851bus:SmallCompaniesRegimeForAccounts2022-11-012023-10-3105919851bus:FRS1022022-11-012023-10-3105919851bus:Audited2022-11-012023-10-3105919851bus:Director12022-11-012023-10-3105919851bus:FullAccounts2022-11-012023-10-31xbrli:purexbrli:sharesiso4217:GBP